Dr. Jack Cush from Dallas, TX reviews the classification of Still's disease, pathogenic considerations and the approach to, and cost of, therapy - including the use of corticosteroids and inhibitors of interleukin-1 (IL-1) an IL-6. This was originally recorded Oct. 11, 2012 for the International Still's Foundation (no longer in existence).
Dr. Cush is the executive editor of RheumNow.com - a news and information resource for rheumatologists and those interested in MSK disorders.
Dr. Cush is the executive editor of StillsNow.com - a new medical education site focused on Still's disease and other febrile autoinflammatory disorders. You can subscribe to the website's monthly email with updated social media, news articles, videos and podcasts for physicians, patients and healthcare providers caring for patients with febrile disorders.
23 июл 2024
